Boehringer Ingelheim claims the discovery of novel arylsulfonamides with analgesic activity March 31, 2009
Biogen Idec reports favorable interim results from phase IIa studies of BIIB-014 in PD March 31, 2009
Oxygen Biotherapeutics adds Israeli clinical trial sites to phase II study of Oxycyte in TBI March 30, 2009
Lilly presents novel substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists March 30, 2009
RSS